Press Release
Category Added in a WPeMatico Campaign
-
Internet2 Announces Election and Appointment of New Board Trustees
WASHINGTON, Nov. 20, 2025 /PRNewswire/ — Internet2 elected one new trustee, re-elected its board vice chair, and appointed five additional trustees…
Read More » -
WebPT Releases 2025 State of Rehab Therapy Report, Pointing to a Pivotal Year for Innovation and Operational Change
Survey data reveals high documentation burden, misalignment between leaders andstaff, and growing interest in technology to streamline operations PHOENIX, Nov.…
Read More » -
New BlueVoyant Report Reveals Increased Investment in Third-Party Risk Management, Yet Major Gaps and Breaches Still Persist
Study finds 97% of organizations report they were negatively impacted by a breach in their supply chain over the past…
Read More » -
openIDL Launches First-Ever Free and Open Production-Ready Insurance Data Standard: openIDS Homeowners Standard v.1.0
Pioneering the Future of Insurance Data with Industry-Wide Adoption through Open, Collaborative Standards openIDL releases the first-ever free and open…
Read More » -
Young Innovations and Umayana Partner to Launch Murnia® Mouth Spray: Natural Moisture for Persistent Oral Dryness and Daily Oral Health Maintenance
Revolutionary Biotechnology-Based Formula with Patented Molecular Compound Delivers Lasting Comfort Through Natural, Moisture-Rich Ingredients and Multi-Mechanism Support ALGONQUIN, Ill., Nov.…
Read More » -
Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors
BOULDER, Colo., Nov. 20, 2025 /PRNewswire/ — Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced…
Read More » -
CATALINA “UNLIMITED” REIMAGINES SHOPPER MARKETING BEYOND GROCERY
New solution empowers brands and retailers to reach high-value shoppers wherever they buy — and prove incremental ROAS ST. PETERSBURG, Fla.,…
Read More » -
Zoomd Technologies to Report Third Quarter 2025 Financial Results
Conference call will be held on November 27, 2025 at 11 AM ET TORONTO, Nov. 20, 2025 /PRNewswire/ — Zoomd Technologies…
Read More » -
Business Wire4 weeks ago
Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer
Test will serve as a companion diagnostic for Bayer’s HYRNUO™ (sevabertinib) to identify patients with NSCLC eligible for HER2-targeted therapy…
Read More » -
Business Wire4 weeks ago
“All Genetic Diseases Could be Cured within a Decade”, Hears Dubai Future Forum
DUBAI, United Arab Emirates–(BUSINESS WIRE)–All known genetic diseases could be cured within the next decade thanks to major advances in…
Read More »







